BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 18458800)

  • 21. The multiple roles of C-type lectin receptors in cancer.
    Li Q
    Front Oncol; 2023; 13():1301473. PubMed ID: 38090489
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Astrocytes Are a Key Target for Neurotropic Viral Infection.
    Potokar M; Zorec R; Jorgačevski J
    Cells; 2023 Sep; 12(18):. PubMed ID: 37759529
    [TBL] [Abstract][Full Text] [Related]  

  • 23. SARS-CoV-2 Receptors and Their Involvement in Cell Infection.
    Avdonin PP; Rybakova EY; Trufanov SK; Avdonin PV
    Biochem (Mosc) Suppl Ser A Membr Cell Biol; 2023; 17(1):1-11. PubMed ID: 37008884
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Current Understanding of Inherited Modifiers of FVIII Pharmacokinetic Variation.
    Swystun LL; Lillicrap D
    Pharmgenomics Pers Med; 2023; 16():239-252. PubMed ID: 36998673
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The XPA Protein-Life under Precise Control.
    Krasikova YS; Lavrik OI; Rechkunova NI
    Cells; 2022 Nov; 11(23):. PubMed ID: 36496984
    [TBL] [Abstract][Full Text] [Related]  

  • 26. ACE2-Independent Alternative Receptors for SARS-CoV-2.
    Lim S; Zhang M; Chang TL
    Viruses; 2022 Nov; 14(11):. PubMed ID: 36423144
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genomic Determinants Potentially Associated with Clinical Manifestations of Human-Pathogenic Tick-Borne Flaviviruses.
    Bondaryuk AN; Kulakova NV; Potapova UV; Belykh OI; Yudinceva AV; Bukin YS
    Int J Mol Sci; 2022 Nov; 23(21):. PubMed ID: 36362200
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of menopausal hormone therapy on methylation levels in early and late postmenopausal women.
    Hilser JR; Hartiala JA; Sriprasert I; Kono N; Cai Z; Karim R; DeYoung J; Mack WJ; Hodis HN; Allayee H
    Clin Epigenetics; 2022 Jul; 14(1):90. PubMed ID: 35850911
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comprehensive Profiling Analysis of CD209 in Malignancies Reveals the Therapeutic Implication for Tumor Patients Infected With SARS-CoV-2.
    Li J; Chen S; Li Y; Zhu Z; Huang H; Wang W; Yang Y; Liang Y; Shu L
    Front Genet; 2022; 13():883234. PubMed ID: 35783255
    [TBL] [Abstract][Full Text] [Related]  

  • 30. SARS-CoV-2-Specific Immune Response and the Pathogenesis of COVID-19.
    Gusev E; Sarapultsev A; Solomatina L; Chereshnev V
    Int J Mol Sci; 2022 Feb; 23(3):. PubMed ID: 35163638
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epigenetic glycosylation of SARS-CoV-2 impact viral infection through DC&L-SIGN receptors.
    Guo L; Liang Y; Li H; Zheng H; Yang Z; Chen Y; Zhao X; Li J; Li B; Shi H; Sun M; Liu L
    iScience; 2021 Dec; 24(12):103426. PubMed ID: 34786539
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Re-Expression of Poly/Oligo-Sialylated Adhesion Molecules on the Surface of Tumor Cells Disrupts Their Interaction with Immune-Effector Cells and Contributes to Pathophysiological Immune Escape.
    Jarahian M; Marofi F; Maashi MS; Ghaebi M; Khezri A; Berger MR
    Cancers (Basel); 2021 Oct; 13(20):. PubMed ID: 34680351
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Innate Immune Response Against HIV-1.
    Murugaiah V; Yasmin H; Pandit H; Ganguly K; Subedi R; Al-Mozaini M; Madan T; Kishore U
    Adv Exp Med Biol; 2021; 1313():23-58. PubMed ID: 34661890
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mechanisms of SARS-CoV-2 entry into cells.
    Jackson CB; Farzan M; Chen B; Choe H
    Nat Rev Mol Cell Biol; 2022 Jan; 23(1):3-20. PubMed ID: 34611326
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Glycosylation on envelope glycoprotein of duck Tembusu virus affects virus replication
    Liu D; Xiao X; Zhou P; Zheng H; Li Y; Jin H; Jongkaewwattana A; Luo R
    Virulence; 2021 Dec; 12(1):2400-2414. PubMed ID: 34506259
    [TBL] [Abstract][Full Text] [Related]  

  • 36. SARS-CoV-2 Impairs Dendritic Cells and Regulates DC-SIGN Gene Expression in Tissues.
    Cai G; Du M; Bossé Y; Albrecht H; Qin F; Luo X; Androulakis XM; Cheng C; Nagarkatti M; Nagarkatti P; Christiani DC; Whitfield ML; Amos CI; Xiao F
    Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502134
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risk Factors Associated with the Clinical Outcomes of COVID-19 and Its Variants in the Context of Cytokine Storm and Therapeutics/Vaccine Development Challenges.
    Hanna J; Tipparaju P; Mulherkar T; Lin E; Mischley V; Kulkarni R; Bolton A; Byrareddy SN; Jain P
    Vaccines (Basel); 2021 Aug; 9(8):. PubMed ID: 34452063
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Activating Natural Killer Cell Receptors, Selectins, and Inhibitory Siglecs Recognize Ebolavirus Glycoprotein.
    Jarahian M; Marstaller K; Banna N; Ahani R; Etemadzadeh MH; Boller LK; Azadmanesh K; Cid-Arregui A; Khezri A; Berger MR; Momburg F; Watzl C
    J Innate Immun; 2022; 14(2):135-147. PubMed ID: 34425576
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neurotropic Viruses, Astrocytes, and COVID-19.
    Tavčar P; Potokar M; Kolenc M; Korva M; Avšič-Županc T; Zorec R; Jorgačevski J
    Front Cell Neurosci; 2021; 15():662578. PubMed ID: 33897376
    [TBL] [Abstract][Full Text] [Related]  

  • 40. SARS-CoV-2 Entry Related Viral and Host Genetic Variations: Implications on COVID-19 Severity, Immune Escape, and Infectivity.
    Huang SW; Wang SF
    Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33802729
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.